Engineers Gate Manager LP Precigen, Inc. Transaction History

Engineers Gate Manager LP

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2023 Aug 14, 2023	SELL	$0.96 - $1.4 $5,975 - $8,713	-6,224 Reduced 32.64%	12,844 $14,000
Q1 2023 May 15, 2023	SELL	$0.88 - $2.19 $4,046 - $10,069	-4,598 Reduced 19.43%	19,068 $20,000
Q4 2022 Feb 14, 2023	SELL	$1.27 - $2.26 $3,685 - $6,558	-2,902 Reduced 10.92%	23,666 $35,000
Q3 2022 Nov 14, 2022	SELL	$1.41 - $2.79 $61,838 - $122,361	-43,857 Reduced 62.27%	26,568 $56,000
Q2 2022 Aug 15, 2022	BUY	$1.15 - $2.53 $80,988 - $178,175	70,425 New	70,425 $94,000

140

161M

232K

69K

Ticker PGEN
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 208,150,000
Market Cap $281M
Description
Precigen, Inc. discovers and develops the next generation of gene and cellular therapies in the United States. It also provides disease-modifying therapeutics; genetically engineered swine for regenerative medicine applications; and reproductive and embryo transfer technologies. In addition, the company offers UltraVector platform that incorpora...

Get notified when there are updates to the investment portfolio of Engineers Gate Manager LP, based on Form 13F filings with the SEC.

Stay updated on Engineers Gate Manager LP with notifications on news.